Methotrexate, Tafasitamab, Lenalidomide and Rituximab in Patients With PCNSL
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Non-Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
A Study of Radiation Therapy Before CAR T Cell Therapy for People With B Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
The Effect of Decision Support System on Symptom Self-Management in Non-Hodgkin Lymphoma Patients
- Status
- COMPLETED
- Phase
- NA
Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1
Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Long-Term Follow-up Study
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Study of 3D189 in Patients With Hematologic Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Evaluation of Safety and Efficacy of Allo GDA-201 Natural Killer (NK) Cells in Patients With Relapsed/Refractory B Cell NHL
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Gentulizumab in Patients With Advanced Solid Malignancies and Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Telehealth Exercise Intervention to Improve Cardiovascular Health in Lymphoma Survivors, TECHS Trial
- Status
- COMPLETED
- Phase
- NA
A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Mosunetuzumab With or Without Polatuzumab Vedotin and Obinutuzumab for the Treatment of Untreated Indolent B-Cell Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1